<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14">
 <label>14</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wattjes</surname>
    <given-names>MP</given-names>
   </name>
   <name>
    <surname>Wijburg</surname>
    <given-names>MT</given-names>
   </name>
   <name>
    <surname>van Eijk</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Frequin</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Uitdehaag</surname>
    <given-names>BMJ</given-names>
   </name>
   <name>
    <surname>Barkhof</surname>
    <given-names>F</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS</article-title>. 
  <source>J Neurol Neurosurg Psychiatry</source> (
  <year>2018</year>) 
  <volume>89</volume>(
  <issue>5</issue>):
  <page-range>535–41</page-range>.  
  <pub-id pub-id-type="doi">10.1136/jnnp-2017-316886</pub-id>
 </mixed-citation>
</ref>
